CY1107352T1 - Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου - Google Patents
Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονουInfo
- Publication number
- CY1107352T1 CY1107352T1 CY20081100328T CY081100328T CY1107352T1 CY 1107352 T1 CY1107352 T1 CY 1107352T1 CY 20081100328 T CY20081100328 T CY 20081100328T CY 081100328 T CY081100328 T CY 081100328T CY 1107352 T1 CY1107352 T1 CY 1107352T1
- Authority
- CY
- Cyprus
- Prior art keywords
- therapeutic purpose
- surgery
- dosage form
- postoperative pain
- operative therapeutic
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 239000006211 transdermal dosage form Substances 0.000 abstract 2
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 abstract 1
- 229960001736 buprenorphine Drugs 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
- Processing Of Meat And Fish (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49036303P | 2003-07-25 | 2003-07-25 | |
| EP04779185A EP1638492B1 (en) | 2003-07-25 | 2004-07-26 | Preoperative treatment of post operative pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107352T1 true CY1107352T1 (el) | 2012-12-19 |
Family
ID=34115386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100328T CY1107352T1 (el) | 2003-07-25 | 2008-03-21 | Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20080026042A1 (enExample) |
| EP (1) | EP1638492B1 (enExample) |
| JP (1) | JP5632573B2 (enExample) |
| KR (4) | KR20080011248A (enExample) |
| CN (1) | CN1829489B (enExample) |
| AT (1) | ATE382354T1 (enExample) |
| AU (1) | AU2004261181B2 (enExample) |
| BR (1) | BRPI0412924A (enExample) |
| CA (1) | CA2529983C (enExample) |
| CY (1) | CY1107352T1 (enExample) |
| DE (1) | DE602004011055T2 (enExample) |
| DK (1) | DK1638492T3 (enExample) |
| EA (1) | EA009213B1 (enExample) |
| ES (1) | ES2299871T3 (enExample) |
| GE (1) | GEP201606538B (enExample) |
| HR (1) | HRP20080146T3 (enExample) |
| IL (1) | IL173345A (enExample) |
| IS (1) | IS8186A (enExample) |
| MA (1) | MA28005A1 (enExample) |
| MX (1) | MXPA06000990A (enExample) |
| NO (1) | NO326636B1 (enExample) |
| NZ (1) | NZ594154A (enExample) |
| PL (1) | PL1638492T3 (enExample) |
| PT (1) | PT1638492E (enExample) |
| UA (1) | UA81689C2 (enExample) |
| WO (1) | WO2005011578A2 (enExample) |
| ZA (1) | ZA200510071B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| DE10361306A1 (de) * | 2003-12-24 | 2005-07-28 | Lts Lohmann Therapie-Systeme Ag | Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür |
| JP2011251944A (ja) * | 2010-06-02 | 2011-12-15 | Kansai Medical Univ | 埋植用鎮痛製剤 |
| DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
| ES2688577T3 (es) | 2010-09-03 | 2018-11-05 | Zoetis Belgium S.A. | Composiciones de buprenorfina en dosis altas y uso como analgésico |
| RU2459640C2 (ru) * | 2010-10-26 | 2012-08-27 | Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" | Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией |
| RU2487734C1 (ru) * | 2011-11-17 | 2013-07-20 | Анатолий Анатольевич Лаврентьев | Способ послеоперационного обезболивания |
| RU178867U1 (ru) * | 2016-05-04 | 2018-04-20 | Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" | Вакуумная микроразмерная кристаллизационная ячейка |
| RU2649961C1 (ru) * | 2017-02-28 | 2018-04-05 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела |
| WO2024055006A2 (en) * | 2022-09-09 | 2024-03-14 | The Regents Of The University Of California | Compositions for preventing transition from acute to chronic pain |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4119713A (en) * | 1977-02-09 | 1978-10-10 | Sam Carosio | Analgesic and anti-inflammatory composition |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| DK0484543T3 (da) * | 1990-04-24 | 1996-01-22 | Teijin Ltd | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| SE9003665D0 (sv) * | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
| JP2669951B2 (ja) * | 1991-03-28 | 1997-10-29 | 雍憲 森本 | 麻薬性鎮痛剤を含有する経皮吸収組成物 |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| CA2174803C (en) * | 1996-04-23 | 2000-07-11 | Jonathan P. Wong | Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug |
| JPH1036265A (ja) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | ブプレノルフィン経皮吸収製剤 |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
| KR100383252B1 (ko) * | 1998-12-17 | 2003-07-16 | 주식회사 삼양사 | 부프레놀핀을함유하는경피투여조성물및이를포함하는패취 |
| DE19901085C2 (de) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps |
| JP4659943B2 (ja) * | 2000-02-25 | 2011-03-30 | 帝三製薬株式会社 | 塩酸ブプレノルフィン含有貼付剤 |
| AU2001262683A1 (en) * | 2000-06-02 | 2001-12-17 | Teijin Limited | Buprenorphine-containing patch |
| GB0026137D0 (en) * | 2000-10-25 | 2000-12-13 | Euro Celtique Sa | Transdermal dosage form |
| US20020106407A1 (en) * | 2000-12-11 | 2002-08-08 | Dennis Coleman | Method and apparatus for treating breakthrough pain |
| DK2113315T3 (da) * | 2001-04-23 | 2014-08-18 | Euro Celtique Sa | Bortskaffelsessystem til transdermal doseringsform |
| PT2062573E (pt) * | 2001-05-01 | 2012-01-11 | Euro Celtique Sa | Sistemas transdérmicos que contêm opióides que resistem a violação |
| DE60235159D1 (de) * | 2001-05-22 | 2010-03-11 | Euro Celtique Sa | Behälter und verfahren zum abgeben transdermaler dosierungsformen |
| MXPA05006334A (es) * | 2002-12-13 | 2005-08-26 | Euro Celtique Sa | Dosis de buprenorfina transdermica para analgesia. |
-
2004
- 2004-07-26 AU AU2004261181A patent/AU2004261181B2/en not_active Ceased
- 2004-07-26 PL PL04779185T patent/PL1638492T3/pl unknown
- 2004-07-26 GE GEAP20049183A patent/GEP201606538B/en unknown
- 2004-07-26 KR KR1020087001559A patent/KR20080011248A/ko not_active Ceased
- 2004-07-26 JP JP2006521306A patent/JP5632573B2/ja not_active Expired - Fee Related
- 2004-07-26 AT AT04779185T patent/ATE382354T1/de active
- 2004-07-26 BR BRPI0412924-5A patent/BRPI0412924A/pt not_active Application Discontinuation
- 2004-07-26 ES ES04779185T patent/ES2299871T3/es not_active Expired - Lifetime
- 2004-07-26 KR KR1020067001687A patent/KR20060054346A/ko not_active Ceased
- 2004-07-26 EA EA200600284A patent/EA009213B1/ru not_active IP Right Cessation
- 2004-07-26 EP EP04779185A patent/EP1638492B1/en not_active Expired - Lifetime
- 2004-07-26 KR KR1020097005038A patent/KR20090031961A/ko not_active Withdrawn
- 2004-07-26 NZ NZ594154A patent/NZ594154A/xx not_active IP Right Cessation
- 2004-07-26 MX MXPA06000990A patent/MXPA06000990A/es active IP Right Grant
- 2004-07-26 HR HR20080146T patent/HRP20080146T3/xx unknown
- 2004-07-26 DE DE602004011055T patent/DE602004011055T2/de not_active Expired - Lifetime
- 2004-07-26 PT PT04779185T patent/PT1638492E/pt unknown
- 2004-07-26 WO PCT/US2004/024009 patent/WO2005011578A2/en not_active Ceased
- 2004-07-26 KR KR1020127027106A patent/KR20120128715A/ko not_active Ceased
- 2004-07-26 DK DK04779185T patent/DK1638492T3/da active
- 2004-07-26 US US10/566,056 patent/US20080026042A1/en not_active Abandoned
- 2004-07-26 CA CA2529983A patent/CA2529983C/en not_active Expired - Fee Related
- 2004-07-26 UA UAA200602137A patent/UA81689C2/ru unknown
- 2004-07-26 CN CN2004800215648A patent/CN1829489B/zh not_active Expired - Fee Related
-
2005
- 2005-12-12 ZA ZA200510071A patent/ZA200510071B/en unknown
- 2005-12-19 IS IS8186A patent/IS8186A/is unknown
-
2006
- 2006-01-24 IL IL173345A patent/IL173345A/en not_active IP Right Cessation
- 2006-02-23 MA MA28831A patent/MA28005A1/fr unknown
- 2006-02-24 NO NO20060912A patent/NO326636B1/no not_active IP Right Cessation
-
2008
- 2008-03-21 CY CY20081100328T patent/CY1107352T1/el unknown
-
2010
- 2010-09-13 US US12/880,952 patent/US20110002975A1/en not_active Abandoned
-
2014
- 2014-01-07 US US14/149,622 patent/US20140221413A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107352T1 (el) | Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου | |
| BRPI0406667A (pt) | Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg | |
| ATE423560T1 (de) | Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form | |
| EA200600820A1 (ru) | Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина | |
| DK1476141T3 (da) | Manipulationssikrede anordninger til transdermal opioidadministration | |
| WO2009129509A3 (en) | Methods and compositions for treating post-operative pain comprising a local anesthetic | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| DE60320770D1 (de) | Verfahren zur verabreichung von buprenorphin zur behandlung von depression | |
| SE0400184D0 (sv) | New therapeutical use | |
| ATE414522T1 (de) | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure | |
| TW200501934A (en) | Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set | |
| ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
| ATE330600T1 (de) | Kombinationspräparat zur krebstherapie | |
| WO2008088987B1 (en) | Treatment of pain with naloxone | |
| Mulroy | Ambulatory Surgery | |
| NO20043774L (no) | The use of devazenide as analgesic agent |